Page last updated: 2024-08-24

iodonitrotetrazolium and Multiple Myeloma

iodonitrotetrazolium has been researched along with Multiple Myeloma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Iversen, PO; Kolset, SO; Negaard, HF; Sandset, PM; Svennevig, K; Østenstad, B	1

Other Studies

1 other study(ies) available for iodonitrotetrazolium and Multiple Myeloma

Article	Year
Associations between regulators of extracellular matrix and hemostatic factors in hematologic neoplasias. Leukemia & lymphoma, 2011, Volume: 52, Issue:6 Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Blood Coagulation Factors; Chronic Disease; Extracellular Matrix; Female; Hematologic Neoplasms; Hemostasis; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Multiple Myeloma; Partial Thromboplastin Time; Syndecan-1; Tetrazolium Salts; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2	2011

Article

Year

Associations between regulators of extracellular matrix and hemostatic factors in hematologic neoplasias.

Leukemia & lymphoma, 2011, Volume: 52, Issue:6

Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Blood Coagulation Factors; Chronic Disease; Extracellular Matrix; Female; Hematologic Neoplasms; Hemostasis; Humans; Leukemia, Lymphoid; Leukemia, Myeloid; Lymphoma, Non-Hodgkin; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Middle Aged; Multiple Myeloma; Partial Thromboplastin Time; Syndecan-1; Tetrazolium Salts; Tissue Inhibitor of Metalloproteinase-1; Tissue Inhibitor of Metalloproteinase-2

2011